Delving into the Latest Updates on Suzhou Yao Ming Bo Rui Biotechnology Co., Ltd. with Synapse

Overview

Tags

Neoplasms

Nervous System Diseases

Therapeutic radiopharmaceuticals

Diagnostic radiopharmaceuticals

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Neoplasms	9
Nervous System Diseases	1

Top 5 Drug Type	Count

Therapeutic radiopharmaceuticals	6
Diagnostic radiopharmaceuticals	4
Small molecule drug	1

Top 5 Target	Count

FAP(Fibroblast activation protein alpha)	2

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 27 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Preclinical

7

1

Phase 1 Clinical

Other

2

Login to view more data

Current Projects

Drug(Targets)	Indications	Global Highest Phase

[18F]BF3-BPA	Brain Cancer More	Phase 1
Lutetium [177Lu ]-BRP-010 ( FAP )	Solid tumor More	Clinical
Gallium [68Ga ]-BRP-010 ( FAP )	Solid tumor More	Clinical
Gallium [68GA ]-Br-54	-	Preclinical
Actinides [225AC ]-br-novel-2	Solid tumor More	Preclinical